Cargando…
An additional NF-κB site allows HIV-1 subtype C to evade restriction by nuclear PYHIN proteins
Subtype C is the most prevalent clade of human immunodeficiency virus type 1 (HIV-1) worldwide. The reasons for this are poorly understood. Here, we demonstrate that a characteristic additional third nuclear factor κB (NF-κB) binding site in the long terminal repeat (LTR) promoter allows subtype C H...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505707/ https://www.ncbi.nlm.nih.gov/pubmed/34551301 http://dx.doi.org/10.1016/j.celrep.2021.109735 |
_version_ | 1784581590888742912 |
---|---|
author | Bosso, Matteo Stürzel, Christina M. Kmiec, Dorota Badarinarayan, Smitha Srinivasachar Braun, Elisabeth Ito, Jumpei Sato, Kei Hahn, Beatrice H. Sparrer, Konstantin M.J. Sauter, Daniel Kirchhoff, Frank |
author_facet | Bosso, Matteo Stürzel, Christina M. Kmiec, Dorota Badarinarayan, Smitha Srinivasachar Braun, Elisabeth Ito, Jumpei Sato, Kei Hahn, Beatrice H. Sparrer, Konstantin M.J. Sauter, Daniel Kirchhoff, Frank |
author_sort | Bosso, Matteo |
collection | PubMed |
description | Subtype C is the most prevalent clade of human immunodeficiency virus type 1 (HIV-1) worldwide. The reasons for this are poorly understood. Here, we demonstrate that a characteristic additional third nuclear factor κB (NF-κB) binding site in the long terminal repeat (LTR) promoter allows subtype C HIV-1 strains to evade restriction by nuclear PYHIN proteins, which sequester the transcription factor Sp1. Further, other LTR alterations are responsible for rare PYHIN resistance of subtype B viruses. Resistance-conferring mutations generally reduce the dependency of HIV-1 on Sp1 for virus production and render LTR transcription highly responsive to stimulation by NF-κB/p65. A third NF-κB binding site increases infectious virus yield in primary CD4(+) T cells in an γ-interferon-inducible protein 16 (IFI16)-dependent manner. Comprehensive sequence analyses suggest that the frequency of circulating PYHIN-resistant HIV-1 strains is increasing. Our finding that an additional NF-κB binding site in the LTR confers resistance to nuclear PYHIN proteins helps to explain the dominance of clade C HIV-1 strains. |
format | Online Article Text |
id | pubmed-8505707 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-85057072021-10-12 An additional NF-κB site allows HIV-1 subtype C to evade restriction by nuclear PYHIN proteins Bosso, Matteo Stürzel, Christina M. Kmiec, Dorota Badarinarayan, Smitha Srinivasachar Braun, Elisabeth Ito, Jumpei Sato, Kei Hahn, Beatrice H. Sparrer, Konstantin M.J. Sauter, Daniel Kirchhoff, Frank Cell Rep Article Subtype C is the most prevalent clade of human immunodeficiency virus type 1 (HIV-1) worldwide. The reasons for this are poorly understood. Here, we demonstrate that a characteristic additional third nuclear factor κB (NF-κB) binding site in the long terminal repeat (LTR) promoter allows subtype C HIV-1 strains to evade restriction by nuclear PYHIN proteins, which sequester the transcription factor Sp1. Further, other LTR alterations are responsible for rare PYHIN resistance of subtype B viruses. Resistance-conferring mutations generally reduce the dependency of HIV-1 on Sp1 for virus production and render LTR transcription highly responsive to stimulation by NF-κB/p65. A third NF-κB binding site increases infectious virus yield in primary CD4(+) T cells in an γ-interferon-inducible protein 16 (IFI16)-dependent manner. Comprehensive sequence analyses suggest that the frequency of circulating PYHIN-resistant HIV-1 strains is increasing. Our finding that an additional NF-κB binding site in the LTR confers resistance to nuclear PYHIN proteins helps to explain the dominance of clade C HIV-1 strains. 2021-09-21 /pmc/articles/PMC8505707/ /pubmed/34551301 http://dx.doi.org/10.1016/j.celrep.2021.109735 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). |
spellingShingle | Article Bosso, Matteo Stürzel, Christina M. Kmiec, Dorota Badarinarayan, Smitha Srinivasachar Braun, Elisabeth Ito, Jumpei Sato, Kei Hahn, Beatrice H. Sparrer, Konstantin M.J. Sauter, Daniel Kirchhoff, Frank An additional NF-κB site allows HIV-1 subtype C to evade restriction by nuclear PYHIN proteins |
title | An additional NF-κB site allows HIV-1 subtype C to evade restriction by nuclear PYHIN proteins |
title_full | An additional NF-κB site allows HIV-1 subtype C to evade restriction by nuclear PYHIN proteins |
title_fullStr | An additional NF-κB site allows HIV-1 subtype C to evade restriction by nuclear PYHIN proteins |
title_full_unstemmed | An additional NF-κB site allows HIV-1 subtype C to evade restriction by nuclear PYHIN proteins |
title_short | An additional NF-κB site allows HIV-1 subtype C to evade restriction by nuclear PYHIN proteins |
title_sort | additional nf-κb site allows hiv-1 subtype c to evade restriction by nuclear pyhin proteins |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505707/ https://www.ncbi.nlm.nih.gov/pubmed/34551301 http://dx.doi.org/10.1016/j.celrep.2021.109735 |
work_keys_str_mv | AT bossomatteo anadditionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT sturzelchristinam anadditionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT kmiecdorota anadditionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT badarinarayansmithasrinivasachar anadditionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT braunelisabeth anadditionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT itojumpei anadditionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT satokei anadditionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT hahnbeatriceh anadditionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT sparrerkonstantinmj anadditionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT sauterdaniel anadditionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT kirchhofffrank anadditionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT bossomatteo additionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT sturzelchristinam additionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT kmiecdorota additionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT badarinarayansmithasrinivasachar additionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT braunelisabeth additionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT itojumpei additionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT satokei additionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT hahnbeatriceh additionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT sparrerkonstantinmj additionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT sauterdaniel additionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins AT kirchhofffrank additionalnfkbsiteallowshiv1subtypectoevaderestrictionbynuclearpyhinproteins |